STOCK TITAN
  1. Home
  2. Sec-filings
  3. CGON
  4. [144] CG Oncology, Inc. SEC Filing

CG Oncology (NASDAQ: CGON) officer plans new sale after $7.95M August trade

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CG Oncology, Inc. (CGON) received a Form 144 notice from officer Ambaw Bellete for a proposed sale of 5,762 shares of common stock. The shares are to be sold following a stock option exercise, with Morgan Stanley Smith Barney LLC listed as the broker. The notice also reports multiple prior sales of CG Oncology common stock by Bellete over the past three months, including several large blocks in July and August 2026.

Positive

  • None.

Negative

  • None.
Shares to be sold 5,762 shares Common stock proposed for sale by Ambaw Bellete under Form 144
Recent sale 08/19/2026 100,000 shares; $7,954,105.00 Common stock sold by Ambaw Bellete during the past 3 months
Recent sale 08/06/2026 75,000 shares; $5,672,212.50 Common stock sale reported in the 3‑month history
Recent sale 07/15/2026 52,438 shares; $3,816,007.65 Common stock sale reported in the 3‑month history
Recent sale 08/10/2026 50,000 shares; $3,770,580.00 Common stock sale reported in the 3‑month history
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Stock Option Exercise financial
"Common | 08/24/2026 | Stock Option Exercise | Issuer |"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
NASDAQ financial
"88640375 | 08/24/2026 | NASDAQ"
The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

What does the Form 144 filed for CGON disclose?
The Form 144 for CG Oncology, Inc. (CGON) discloses that officer Ambaw Bellete intends to sell 5,762 shares of CG Oncology common stock, to be sold in connection with a stock option exercise through a broker.

How many CGON shares does Ambaw Bellete plan to sell under this Form 144?
Ambaw Bellete plans to sell 5,762 shares of CG Oncology common stock. This amount appears as the number of common shares in both the securities information and the securities-to-be-sold sections of the notice.

What is the method of sale for the CGON shares in this Form 144?
The Form 144 states the method as a Stock Option Exercise with consideration in cash. Morgan Stanley Smith Barney LLC Executive Financial Services is listed as the broker handling the shares.

Who is selling CGON shares according to this Form 144?
The seller is Ambaw Bellete, identified as an officer of CG Oncology, Inc. The filing covers shares to be sold for Bellete’s account and lists prior sales that must be aggregated under Rule 144.

What prior CGON stock sales by Ambaw Bellete are reported in the last 3 months?
The notice lists multiple earlier sales of CG Oncology common stock, including 100,000 shares on 08/19/2026, 75,000 shares on 08/06/2026, and several blocks of 50,000 shares and 52,438 shares in July and August 2026.

On which market is CG Oncology (CGON) stock indicated in this Form 144?
The securities information section identifies the market for CG Oncology common stock as NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR